NEW YORK (GenomeWeb) – Foundation Medicine reported after the close of the market on Wednesday that its third quarter revenues jumped 100 percent year over year and the number of clinical tests reported grew 149 percent.

The Cambridge, Mass.-based cancer genomic analysis firm reported total revenues of $16.4 million for the three months ended Sept. 30, up from $8.2 million in Q3 2013 and $14.5 million in Q2 2014. It beat the consensus Wall Street estimate for revenues of $15.7 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Jay Shendure and his colleagues have developed a new method to more comprehensively identify human cell types, the NY Times reports.

Researchers in the UK and Japan have shown that infertility in mice with three sex chromosomes can be overcome, according to the Guardian.

China is embracing preimplantation genetic diagnosis, Nature News reports. 

In PLOS this week: host genetic factors associated with cervical neoplasia progression, population patterns for an ancient flowering rainforest plant, and more.

Sponsored by
Philips Genomics

This webinar will present an in-depth look at how Memorial Sloan Kettering Cancer Center has developed and implemented a next-generation sequencing panel for mutational tumor profiling of advanced cancer patients.

Sponsored by
Fabric Genomics

This webinar will discuss the critical role that software can play for clinical labs looking to establish comprehensive genomic testing programs.